Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Arzeda
company
About
Arzeda develops enzyme design technology to create entirely novel designer cell factories capable of industry-scale chemical production.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $613.01K
- Industries
- Biotechnology,Information Services,Information Technology,Manufacturing
- Founded date
- Jan 1, 2008
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Arzeda develops enzyme design technology that presents a new way of thinking about biocatalysis. The company was founded by David Baker and three senior members of his lab to commercialize and further develop its computational enzyme design technology.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
4
$2.24M
Arzeda has raised a total of
$2.24M
in funding over 2 rounds. Their latest funding was raised on
Feb 18, 2015 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 18, 2015 | Grant | $1.26M | 1 |
National Science Foundation
|
— | Detail |
| Jun 21, 2013 | Grant | $225K | 1 |
National Science Foundation
|
— | Detail |
| Apr 4, 2013 | Grant | $613.01K | 1 |
National Science Foundation
|
— | Detail |
| Dec 8, 2009 | Grant | $149K | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
3
1
Arzeda is funded by 1 investors.
National Science Foundation
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
